The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding

European Journal of Pharmacology

Volumn 571, Issue 1, 2007, Pages 39-43

  Boctor, Sherin Y ^a   Martinez Jr , Joe L ^a   Koek, Wouter ^b   France, Charles P ^b  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

(Rat); AM251; Cannabinoid receptor; Methamphetamine; Reinstatement; Self administration

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; METHAMPHETAMINE; SODIUM CHLORIDE; TETRAHYDROCANNABINOL; CENTRAL STIMULANT AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RELAPSE; ANIMAL; BODY TEMPERATURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELF ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; REINFORCEMENT; TIME; WISTAR RAT;

ANIMALS; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 34548007947     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.004     Document Type: Article

References (30)

1. Anggadiredja K., Nakamichi M., Hiranita T., Tanaka H., Shoyama Y., Watanabe S., and Yamamoto T. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29 (2004) 470-1478
2. Anggadiredja K., Sakimura K., Hiranita T., and Yamanoto T. Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward. Brain Res. 24 (2004) 272-276
3. Bray G.A. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann. Intern. Med. 119 (1993) 707-713
4. 1 receptor antagonism reduced conditioned reinstatement of ethanol-seeking behavior in rats. Eur. J. Neurosci. 21 (2005) 2243-2251
5. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., Vanderschuren L.J., and Schoffelmeer A.N. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7 (2001) 1151-1154
6. Fattore L., Cossu G., Martellotta C.M., and Fratta W. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology 156 (2001) 410-416
7. 1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology 48 (2005) 1097-1104
8. Fattore L., Spano J.S., Deiana S., Melis V., Cossu G., Fadda P., and Fratta W. An endocannabinoids mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives. Brain. Res. Rev. 53 (2007) 1-16
9. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 81 (2005) 263-284
10. Greenhill L.L. The science of stimulant abuse. Pediatr. Ann. 35 (2006) 552-556
11. Kroutil L.A., Van Brunt D.L., Herman-Stahl M.A., Heller D.C., Bray R.M., and Penne M.A. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 84 (2006) 135-143
12. Landa L., Slais K., and Sulcova A. Impact of cannabinoid receptor ligands on behavioural sensitization to antiaggressive methamphetamine effects in the model of mouse agonistic behaviour. Neuro Endocrinol. Lett. 27 (2006) 703-710
13. Landa L., Sulcova A., and Slais K. Involvement of cannabinoid CB1 and CB2 receptor activity of behavioral sensitization to methamphetamine effects in mice. Neuro Endocrinol. Lett. 27 (2006) 63-69
14. Lebovitz H.E. Therapeutic options in development for management of diabetes: pharmacologic agents and new technologies. Endocr. Pract. 12 S1 (2006) 142-147
15. Lesscher H.M., Hoogveld E., Burbach J.P., van Ree J.M., and Gerrts M.A. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur. Neuropsychopharmacol. 15 (2005) 31-37
16. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., and Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42 (1999) 769-776
17. Maldonado R., Valverde O., and Berrendero F. Involvement of the endocannabinoids system in drug addiction. Trends Neurosci. 29 (2006) 225-232
18. Mechoulam R., and Hanus L. The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection. Pain Res. Manag. 6 (2001) 67-73
19. Patel P.N., and Pathak R. Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity. Am. J. Health Syst. Pharm. 64 (2007) 481-489
20. Pozzi O., Misiano P., Clark G.D., and Visentin L. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A. Pharmacology 69 (2003) 158-163
21. Results from the 2004 National Survey on Drug Abuse: National Findings (Office of Applied Studies, NSDUH Series H-28, DHHS Publication No. SMA 05-4062), Rockville, MD (2005)
22. Siu E.C., and Tyndale R.F. Non-nicotinic therapies for smoking cessation. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 541-564
23. Takahashi R.N., and Singer G. Self-administration of delta 9-tetrahydrocannabinol by rats. Pharmacol. Biochem. Behav. 11 (1979) 737-740
24. Tanda G., Munzar P., and Goldberg S.R. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 3 (2000) 1073-1074
25. Trang, T., Sutak, M., Jhamandas, K., in press. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Neurosci. doi:10.1016/j.neuroscience.2007.02.031.
26. Vinklerova J., Novakova J., and Sulcova A. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J. Psychopharmacol. 16 (2002) 139-143
27. 9-tetrahydrocannabinol in adolescent and adult rats. J. Pharmacol. Exp. Ther. 320 (2007) 1097-1105
28. 1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 26 (2006) 8531-8536
29. Yamamoto T., Anggadiredja K., and Hiranita T. New perspectives in the studies on endocannabinoid and cannabis: a role for the endocannabinoid-arachidonic acid pathway in drug reward and long-lasting relapse to drug taking. J. Pharmacol. Sci. 96 (2004) 383-388
30. Yokel R.A., and Pickens R. Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J. Pharmacol. Exp. Ther. 187 (1973) 27-33